Abhinav Shukla
Patrimonio netto: 671 995 $ in data 30/09/2026
Patrimonio netto: 671 995 $ in data 30/09/2026
Abhinav A. Shukla is currently Chief Technical Officer at Shattuck Labs, Inc. since 2021.
Former positions include Chief Technical Operations Officer at Redpin Therapeutics, Inc. (2020–2021), Vice President-Manufacturing at CRISPR Therapeutics AG (2019), VP & Head-Biologics Process Development at Shire Plc (2019), Senior VP-Process Development & Manufacturing at KBI Biopharma, Inc. (2011–2018), Principal Scientist at Amgen, Inc., and Director-Manufacturing Sciences & Technology at Bristol Myers Squibb Co. Education includes a doctorate from Rensselaer Polytechnic Institute and undergraduate and graduate degrees from Indian Institute of Technology New Delhi.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 06/07/2026 | 98.533 ( 0,1% ) | 671 995 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SHATTUCK LABS, INC. | Direttore Tecnico/Scientifico/R&S | 01/06/2021 |
| Società | Posizione | Fine |
|---|---|---|
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders | Direttore Tecnico/Scientifico/R&S | 01/06/2021 |
| CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 01/11/2019 |
| SHIRE | Corporate Officer/Principal | 01/11/2019 |
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Corporate Officer/Principal | 01/06/2018 |
| AMGEN INC. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Commercial Services |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indian Institute of Technology New Delhi
Indian Institute of Technology New Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Shattuck Labs, Inc.
Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale